Related Experiment Video
Updated: Oct 20, 2025

Implantation of Total Artificial Heart in Congenital Heart Disease
Published on: July 18, 2014
Acute respiratory failure on a low dose of amiodarone - is it an underdiagnosed and undertreated condition?
Mijo Meter1, Ivana Kuzmić Prusac2, Duška Glavaš1
1Department of Cardiology, University Hospital Centre Split, Spinčićeva 1, 21000, Split, Croatia.
Abstract:
Amiodarone-induced pulmonary toxicity (AIPT) has a variety of presentations. Amiodarone use has been rarely associated with the development of acute respiratory failure. We present a patient with a history of paroxysmal atrial fibrillation who developed acute respiratory distress syndrome despite taking a low dose of amiodarone and having no risk or precipitating factors. The diagnosis of AIPT was made after drug discontinuation and exclusion of other potential causes. The development of acute respiratory failure due to AIPT is often underdiagnosed and undertreated. Better identification of risk factors and developing appropriate diagnostic tools for risk stratification of patients receiving amiodarone is mandatory.
Insights
Amiodarone-induced pulmonary toxicity (AIPT) can cause acute respiratory failure, even at low doses. Early diagnosis and risk factor identification are crucial for managing this rare but serious condition.
Area of Science:
- Pulmonology
- Cardiology
- Pharmacology
Background:
- Amiodarone is an antiarrhythmic drug used for atrial fibrillation.
- Amiodarone-induced pulmonary toxicity (AIPT) is a rare but serious adverse effect.
- AIPT can present with diverse clinical manifestations.
Observation:
- A patient with paroxysmal atrial fibrillation developed acute respiratory distress syndrome.
- The patient was on a low dose of amiodarone.
- No specific risk or precipitating factors for AIPT were identified in this case.
Findings:
- Amiodarone use was rarely associated with acute respiratory failure.
- Diagnosis of AIPT was confirmed after amiodarone discontinuation and exclusion of other causes.
- Acute respiratory failure due to AIPT is often underdiagnosed and undertreated.
Implications:
- Better identification of risk factors for AIPT is needed.
- Development of diagnostic tools for risk stratification in patients on amiodarone is mandatory.
- Increased awareness can improve diagnosis and treatment of AIPT.
More Related Videos
08:28Methods for ECG Evaluation of Indicators of Cardiac Risk, and Susceptibility to Aconitine-induced Arrhythmias in Rats Following Status Epilepticus
Published on: April 5, 2011
08:56Sterile Pericarditis in Aachener Minipigs As a Model for Atrial Myopathy and Atrial Fibrillation
Published on: September 24, 2021
Related Concept Videos
Acute Respiratory Failure-I
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Acute Respiratory Failure-III
Acute Respiratory Failure-IV
Acute Respiratory Failure-II
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
Acute Respiratory Failure-V
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Cardiomyopathy II: Dilated Cardiomyopathy